Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Pulsed-Field Ablation: Proximity to Coronary Vessels and the Unresolved Issue of Induced Vasospasm

Pulsed-field ablation (PFA) has emerged as a promising technique in the treatment of atrial fibrillation, thanks to its ability to generate precise myocardial lesions with a superior safety profile compared to conventional ablation. It is a non-thermal method with greater tissue specificity.

Evolución de pacientes jóvenes con miocardiopatía hipertrófica tratados con ablación septal por alcoholización.

However, its extrapulmonary application—such as in the cavotricuspid isthmus (CTI) or the mitral isthmus (MI)—has raised concerns in early studies, given the possibility of coronary spasm due to the proximity of these structures to epicardial coronary vessels.

In this context, Tam et al. published an observational study that assessed, using OCT, the immediate and short-term structural changes in coronary arteries subjected to PFA.

Twenty-one patients treated with PFA for atrial flutter were included. Of them, 19 completed the imaging study series before, during, and three months after the procedure. As part of the protocol, nitroglycerin (NTG) was administered preventively in the corresponding arteries.

At three months, the ablation site showed significant increase in vascular wall area (WA), which rose from 2.69 mm² to 3.21 mm², equivalent to a 17.1-% remodeling (p <0.01). Additionally, the corrected lumen area (cLA) decreased from 6.92 mm² to 5.41 mm², accounting for a 10.1-% reduction (p <0.001).

Read also: TRIPLACE Registry: Conduction Disorders Following Transcatheter Tricuspid Valve Replacement.

These structural changes were not detected at remote reference sites, where the vascular wall remained relatively unchanged (ΔWA: 0.12 mm²; p = 0.926) and the corrected lumen area remained stable.

As for acute coronary spasm, it was documented in 75% of vessels (mild, 15%; moderate, 15%; severe, 45%). Acute lumen reduction showed a nonsignificant trend toward correlation with lumen loss at three months (r = 0.41, p = 0.08), suggesting a possible pathophysiological link between spasm and vascular remodeling.

Although, in terms of percentage, the structural modifications at three months are not striking (10.1% in corrected lumen area), their clinical impact could be relevant in patients with preexisting coronary artery disease, by altering the prognosis of intermediate or severe lesions.

Read also: Is It Useful to Index the Minimum Lumen Area to Ventricular Mass to Identify Functional Left Main Coronary Stenosis?

While there were no major short-term events—such as myocardial infarction or cardiovascular death—prolonged monitoring is essential, as the long-term clinical effect of these PFA-induced structural changes remains unknown.

Conclusions

Pulsed-field ablation for atrial flutter (CTI/MI), when applied in proximity to coronary arteries, may induce subclinical vascular remodeling, which justifies the need for prolonged follow-up in this population. This study was the first to demonstrate, quantitatively and through serial OCT, a potentially adverse impact.

Original Title: Effect of Pulsed-Field Ablation on Human Coronary Arteries. A Longitudinal Study With Intracoronary Imaging.

Reference: Tam MTK, Chan JYS, Chan CP, Wu EB, Lai A, Au ACK, Chi WK, Tan G, Yan BP. Effect of Pulsed-Field Ablation on Human Coronary Arteries: A Longitudinal Study With Intracoronary Imaging. JACC Clin Electrophysiol. 2025 Jul;11(7):1478-1488. doi: 10.1016/j.jacep.2025.03.014. Epub 2025 Apr 24. PMID: 40278817.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...